F.A.S. Politi et al.
Acta Tropica 219 (2021) 105920
MeOD-d4) δ 7.05 (d, J = 3.7 Hz, 1H), 7.01 (d, J = 4.1 Hz, 2H), 6.90 (d, J
nonencapsulated compound and obtain nonaggregated nanoparticles.
The particle size and the polydispersity index (PDI) of the prepared
piperine nanoparticles were characterized using dynamic light scat-
tering (DLS) with a submicron particle size analyzer (Zetasizer Nano-
ZS™, Malvern Panalytical Instruments, UK), equipped with 4.0 mV He-
=
3.6 Hz, 1H), 4.70 (s, 2H), 3.72 (t, J = 6.7 Hz, 2H), 2.65 (t, J = 6.7 Hz,
13
2
H) C NMR (63 MHz, MeOD-d4) δ 146.12, 139.17, 137.49, 133.31,
1
26.83, 124.72, 124.12, 123.76, 93.30, 75.31, 61.49, 60.01, 24.52.
′
Compound 2d, a slight modification of 5-(4-hydroxybut-1-inyl)-2,2 -
◦
bithiophene previously identified in a crude ethanolic extract from the
Ne laser (λ = 633 nm), applying 175 detection angle to DTS1070
aerial parts of T. patula will be referred to as Thio1.
capillary cuvettes. The zeta potential was characterized using the same
instrument with a zeta potential analyzer by determining the electro-
phoretic mobility of nanoparticles under an electrical field. All mea-
surements were performed in triplicate.
2
2
.7. In vitro bioassays
.7.1. Egg hatch test (EHT)
The egg hatch test was performed with the samples of Thio1 and
2.9. In vivo bioassay
Thio2 in order to choose the most appropriate compound for the prep-
aration of the nanostructured formulation to be administered in the in
vivo test. The faeces were directly collected from the rectal ampoule of
the Santa In ˆe s sheep and later processed according to the technique of
Coles et al. (1992) modified by Bizimenyera et al. (2006). Approxi-
mately 100 eggs per volume of H. contortus were placed in each well of a
2.9.1. Fecal egg count reduction test (FECRT)
Santa In
ˆe s sheep aged between 8 and 9 months were used (Embrapa
Pecu
a´ ria Sudeste Ethics Committee on Animal Experimentation, process
n. 04/2017). For artificial infection, the animals received oral treatment
with the organophosphate trichlorfon (Neguvon®, Bayer, Germany), 1
ꢀ 1
2
4-well cell culture plate and the volume was completed to 250 µL using
mL.kg from a 10% (v/v) solution. After three consecutive measure-
ments with zero egg counts in the fecal mass of the sheep, each animal
distilled water. Then, 250 µL of the each test samples were added,
obtaining final concentrations ranging from 4 to 0.001 mg.mL (15 to
ꢀ 1
3
was inoculated with approximately 4,000 larvae (L ) of H. contortus
ꢀ 3
3
.75 × 10 mM). The negative control consisted of distilled water and
from the Embrapa 2010 isolate, characterized as resistant to benzimid-
azoles, imidazothiazoles and macrocyclic lactones (Chagas et al. 2013).
After 28 days of artificial infection, the sheep were weighed, and their
fecal matter was collected directly from the rectum of the animals in
order to proceed to the egg count per gram of faeces [EPG] (Ueno and
Gonçalves 1998).
Tween 80 2% v/v (Sigma-Aldrich, USA), and a positive control with
ꢀ 1
thiabendazole (Sigma-Aldrich, USA) at 60 g.mL was used (Gainza
μ
et al., 2015; Gainza et al., 2016). The test was performed with six rep-
etitions. The plates were homogenized manually and stored in a
◦
Biochemical Oxygen Demand incubator BOD (27 C and 80% RH) for 24
hours. The results were measured by adding a drop of lugol to each well,
The animals were distributed through three test groups with n = 10,
constructed in order to be homogeneous in relation to the initial para-
sitic load and weight: (i) negative control (untreated); (ii) positive
control (Zolvix™ (monepantel), Elanco, USA); (iii) nano Thio1 group.
Determination of the doses to be orally administered were calculated
according to the weight of the animals (2.5 mg of each product/kg of live
weight). During the period of the experiment, the animals were kept in
housed in individual metabolic cages (2.68 × 0.80 × 2.02 m, L x W x H),
receiving controlled feed and water ad libitum. The animals had daily
veterinary follow-ups to observe any adverse reactions to the products
administered, as well as other signs that pointed to a disorder in its vital
conditions (anemia by Famacha scoring system, body temperature,
diarrhea, foam in the mouth, etc). The EPG count was performed for all
1
and the eggs and hatched L were counted. These data were used to
calculate the percent hatchability inhibition, according to the equation
below:
(
Num ber of eggs)
EHT =
x 100
(
Num ber of eggs + Num ber of L1)
2
.7.2. Larval development test (LDT)
Approximately 100 eggs recovered from sheep faeces were placed in
each well of a 24-well plate together with 10 µL of amphotericin B
ꢀ 1
(
0.125 mg.mL stock solution) and 20 µL of nutrient medium, diluting
to a volume of 250 µL with distilled water (Hubert and Kerboeuf 1992).
◦
The plates were incubated (27 C and 80% RH), and after 24 hours, 250
2
groups on day 0 (EPG ) and after 3, 7, 10, 14, 17, 21, 24 and 29 days. In
µL of the test solutions were added to L
1
, obtaining concentrations from
order to check whether the formulation had any effect on the hatch-
ability of eggs, fecal samples from animals in the negative control group
and in the group treated with nano Thio1 were collected 2, 9, 16, 23 and
ꢀ 1
ꢀ 3
1
0.0 to 0.002 mg.mL (37 to 7.57 × 10 mM). The negative control
consisted of
a dimethyl sulfoxide solution 0.5% v/v (DMSO,
Sigma-Aldrich, USA) and distilled water, and a positive control with
3
0 days after treatment to perform the EHT. The calculation of the ef-
ꢀ 1
ivermectin (Sigma-Aldrich, USA) at 0.01 mg.mL was used (Gainza
et al., 2015; Gainza et al., 2016; Politi et al., 2018). The test was per-
ficacy of nano Thio1 was carried out using the following equation
(
Wursthorn and Martin, 1990):
formed in six repetitions. After incubation for 6 days, live L
1
+ L
2 3
and L
(
%)Efficacy(Sample) = EPG
Control ꢀ EPGSample
x 100
larvae were counted to estimate the percent inhibition of larval devel-
opment, according to the equation:
EPGControl
(
L1 + L2)
LDT =
x 100
2.10. Molecular modeling studies
(
Total num ber of larvae)
The H. contortus GluCl (UniProt ID P91730) primary structure was
submitted to the BLASTP server (blast.ncbi.nlm.nih.gov) to search against
the Protein Data Bank (PDB) for the crystallographic structure with the
highest sequential identity and sequence cover. Caenorhabditis elegans
GluCl cocrystallized with ivermectin (PDB ID: 3RHW) was selected
(Hibbs and Gouaux 2011). The Chains A and B located in the trans-
membrane domain were prepared for molecular modeling studies using
the Protein Preparation tool available on the Maestro v.10.8 interface
(Schr o¨ dinger, USA). Solvent molecules and the cocrystallized ligands
were removed, and hydrogen atoms were added to the protein model.
The protonation state for histidine, glutamine and asparagine residues at
pH 7 ± 2 was optimized, as well as the hydrogen bonds. Energy mini-
mization was performed using the OPLS2003 force field. Nonconserved
2
.8. Preparation and characterization of polycaprolactone nanoparticles
containing Thio1
The polymeric nanoparticles (nano Thio1) were prepared by the
nanoprecipitation method (Fessi et al. 1999). Briefly, the organic phase
(
OP) containing thiophene (Thio1, 375 mg), polycaprolactone (PCL,
875 mg, Sigma Aldrich, USA) and acetone (50 mL) was slowly dripped
into the aqueous phase (AP) containing 0.5% surfactant (poloxamer
07, 100 mL, Sigma-Aldrich, USA) under magnetic stirring (1000 rpm)
in an exhaust hood until complete solvent evaporation. The resulting
suspension was subjected to filtration (0.45 m membranes), followed
by ultracentrifugation (40,000 rpm), in order to eliminate the
1
4
μ
4